How is the Transmucosal Drug Delivery Devices Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Predicted Annual Growth Rate of the Transmucosal Drug Delivery Devices Market Over the Coming Decade?
The market for transmucosal drug delivery devices has been experiencing significant growth in the recent past. The market, which is currently valued at $50.24 billion in 2024, is projected to expand to $55.04 billion in 2025, representing a compound annual growth rate (CAGR) of 9.6%. This expansion during the historical period has been fueled by factors such as the demand for immediate angina relief, the proven efficiency of sublingual delivery for swift absorption into the bloodstream, preference to evade gastrointestinal degradation, advancements in buccal tablets, and the necessity for non-invasive delivery of peptides and proteins.
Expectations indicate that the transmucosal drug delivery devices market will experience robust growth in the upcoming years, ultimately reaching a market size of $78.21 billion by 2029. This represents a compound annual growth rate (CAGR) of 9.2%. Factors contributing to this anticipated growth during the forecasted period include advances in smart drug delivery systems, rising incidences of chronic diseases, increased emphasis on personalized medicine, an older population with increased medication needs, and heightened awareness. Key trends during this period would be the expansion in therapeutic applications, personalized medicine influencing the customization of drug delivery devices, regulatory approvals and guidelines, emerging markets, environmentally friendly devices, and innovative drug formulations.
What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Transmucosal Drug Delivery Devices Market?
The transmucosal drug delivery devices market is poised for growth, catalyzed by the increasing incidence of chronic illnesses. These are long-term conditions that generally evolve slowly over time, necessitating continuous medical intervention to manage symptoms and avert complications. The emergence of chronic diseases can be traced back to lifestyle choices, aging populations, environmental factors, issues with healthcare systems, and urbanization. Transmucosal drug delivery devices come into play in the treatment of these chronic ailments by ensuring regulated and effective medication delivery, maintaining therapeutic levels to manage symptoms and enhance patient compliance. As an example, a report published in August 2023 by the Leukemia & Lymphoma Society (LLS), a charitable organization based in the US, shed light on the fact that someone in the US gets diagnosed with leukemia, lymphoma, or myeloma every three minutes. It is projected that in 2023, around 184,720 individuals will receive these diagnoses, accounting for 9.4% of the estimated 1,958,310 new cancer cases for the year. Consequently, the mounting prevalence of chronic illnesses is propelling the transmucosal drug delivery devices market.
Get Your Free Sample of the Global Transmucosal Drug Delivery Devices Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp
What Are the Major Players Making an Impact in the Transmucosal Drug Delivery Devices Market’s Growth?
Major companies operating in the transmucosal drug delivery devices market are:
• Johnson & Johnson
• Bayer AG
• Sanofi SA
• Bristol-Myers Squibb Company
• Abbott Laboratories
Which Upcoming Trends Are Set to Influence the Transmucosal Drug Delivery Devices Market’s Path Forward?
Leading businesses in the transmucosal drug delivery devices market are prioritizing the development of innovative smart platforms, such as unique transdermal patch delivery systems, which amplify drug absorption and boost patient adherence and convenience. These exclusive transdermal patch delivery mechanisms relate to advanced technologies possessed by companies for delivering medications through the skin for controlled release, and improved therapeutic results. For example, Starton Therapeutics Inc, an American biotech firm, introduced STARSILON in January 2024. STARSILON is a groundbreaking proprietary transdermal patch delivery system that functions for an extended period to facilitate the therapeutic delivery of complex-to-formulate APIs. It broadens the scope of transdermal drug delivery for challenging active pharmaceutical ingredients (APIs), improving therapeutic effectiveness via prolonged delivery rates.
Get Instant Access to the Global Transmucosal Drug Delivery Devices Market Report with Swift Delivery!
Which Key Segments Stand Out in Understanding the Composition of the Transmucosal Drug Delivery Devices Market?
The transmucosal drug delivery devices market covered in this report is segmented –
1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery
2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types
3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals
Subsegments:
1) By Passive Transdermal Drug Delivery: Reservoir Systems, Matrix Systems, Micro-Needle Systems, Pressure-Sensitive Adhesive Systems
2) By Active Transdermal Drug Delivery: Iontophoresis, Sonophoresis, Electroporation, Thermal Ablation, Microporation
What Regions Are Steering Growth in the Transmucosal Drug Delivery Devices Sector?
North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can We Define the Transmucosal Drug Delivery Devices Market and Its Key Components?
Transmucosal drug delivery devices are medical devices designed to deliver drugs through the mucous membranes, such as those in the mouth, nose, or rectum, for rapid absorption into the bloodstream. These devices are used to administer medications that are poorly absorbed by the gastrointestinal tract or that require quick onset of action, such as pain relief or hormone therapy. Their purpose is to bypass the digestive system, providing a more direct and efficient route for drug delivery.
Browse Through More Similar Reports By The Business Research Company:
Implantable Drug Delivery Devices Global Market Report 2024
Injectable Drug Delivery Devices Global Market Report 2024
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
